Mechanism-Focused Randomized Controlled Trials in Youths: Another Step Uphill

Argyris Stringaris,Jamilah Silver

DOI: https://doi.org/10.1176/appi.ajp.20240123

IF: 17.7

2024-04-03

American Journal of Psychiatry

Abstract:In this issue, Hwang et al. (1) report on a randomized controlled trial (RCT) of intranasal oxytocin for young people (mean age around 14 years) with severe irritability. For clinicians, RCTs like that of Hwang et al. hold the important promise of direct clinical translation. RCTs are the best way to estimate the causal effect of a treatment on a given outcome. In the best-case scenario, randomization balances (and therefore neutralizes) confounders, and the presence of an adequate and blinded control condition allows one to estimate the effect of the intervention net of biases such as expectation. The Hwang et al. study is appealing for an additional reason in that it tests a fairly clearly articulated mechanistic hypothesis. The authors' idea is that oxytocin may be beneficial to children with severe irritability by changing the way they process emotions, as measured using functional MRI (fMRI). Combining the rigor of RCTs with a mechanistic hypothesis could catalyze the much-needed change in our field and facilitate early, rational interventions.

psychiatry